Blue Water Life Science Advisors

Latest statistics and disclosures from Blue Water Life Science Advisors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ADPT, GH, NTRA, PSNL, CDNA, and represent 89.92% of Blue Water Life Science Advisors's stock portfolio.
  • Added to shares of these 1 stock: TEM (+$5.8M).
  • Started 1 new stock position in TEM.
  • Reduced shares in these 5 stocks: TXG (-$13M), AKYA (-$6.1M), NTRA, CDNA, GH.
  • Sold out of its positions in AKYA, TXG.
  • Blue Water Life Science Advisors was a net seller of stock by $-22M.
  • Blue Water Life Science Advisors has $110M in assets under management (AUM), dropping by -13.24%.
  • Central Index Key (CIK): 0001789778

Tip: Access up to 7 years of quarterly data

Positions held by Blue Water Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Blue Water Life Science Advisors

Blue Water Life Science Advisors holds 7 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Adaptive Biotechnologies Cor (ADPT) 29.3 $32M 2.1M 14.96
 View chart
Guardant Health (GH) 23.1 $25M -7% 406k 62.48
 View chart
Natera (NTRA) 20.8 $23M -15% 142k 160.97
 View chart
Personalis Ord (PSNL) 10.0 $11M 1.7M 6.52
 View chart
Caredx (CDNA) 6.8 $7.4M -29% 510k 14.54
 View chart
Tempus Ai (TEM) 5.3 $5.8M NEW 72k 80.71
 View chart
Quanterix Ord (QTRX) 4.7 $5.2M 958k 5.43
 View chart

Past Filings by Blue Water Life Science Advisors

SEC 13F filings are viewable for Blue Water Life Science Advisors going back to 2020

View all past filings